UNDERWRITING AGREEMENTUnderwriting Agreement • July 22nd, 2015 • Fibrocell Science, Inc. • Pharmaceutical preparations • New York
Fibrocell Science, Inc., a Delaware corporation (the “Company”), proposes to sell 2,586,206 shares (the “Firm Stock”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”) an option to purchase up to 387,930 additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
